NutriBand Inc. (NTRB) stock
NTRBNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends January 31
Financials through Q2 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 4, 2026Score 4/30239% above fair value
$5.59−0.22 (-3.79%)
Close on Nov 17, 2026Market cap $67.95MP/E –Yield –
NutriBand ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
NutriBand's ebitda for the twelve months ending Jul 31, 2026 was -$6.90M. For fiscal 2026 it was -$8.12M. The highest annual figure on record is -$1.90M in fiscal 2020.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | -$8.12M | – |
| FY2025 | Jan 31, 2025 | -$10.00M | – |
| FY2024 | Jan 31, 2024 | -$4.58M | – |
| FY2023 | Jan 31, 2023 | -$4.15M | – |
| FY2022 | Jan 31, 2022 | -$5.80M | – |
| FY2021 | Jan 31, 2021 | -$2.44M | – |
| FY2020 | Jan 31, 2020 | -$1.90M | – |
| FY2019 | Jan 31, 2019 | -$3.29M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2027CQ2 2026 | Jul 31, 2026 | -$857.31K | – |
| Q1 FY2027CQ1 2026 | Apr 30, 2026 | -$1.22M | – |
| Q4 FY2026CQ4 2025 | Jan 31, 2026 | -$985.04K | – |
| Q3 FY2026CQ3 2025 | Oct 31, 2025 | -$3.84M | – |
| Q2 FY2026CQ2 2025 | Jul 31, 2025 | -$1.95M | – |
| Q1 FY2026CQ1 2025 | Apr 30, 2025 | -$1.36M | – |
| Q4 FY2025CQ4 2024 | Jan 31, 2025 | -$5.49M | – |
| Q3 FY2025CQ3 2024 | Oct 31, 2024 | -$1.35M | – |
| Q2 FY2025CQ2 2024 | Jul 31, 2024 | -$1.34M | – |
| Q1 FY2025CQ1 2024 | Apr 30, 2024 | -$1.82M | – |
| Q4 FY2024CQ4 2023 | Jan 31, 2024 | -$1.24M | – |
| Q3 FY2024CQ3 2023 | Oct 31, 2023 | -$1.66M | – |
| Q2 FY2024CQ2 2023 | Jul 31, 2023 | -$748.88K | – |
| Q1 FY2024CQ1 2023 | Apr 30, 2023 | -$942.68K | – |
| Q4 FY2023CQ4 2022 | Jan 31, 2023 | -$1.61M | – |
| Q3 FY2023CQ3 2022 | Oct 31, 2022 | -$971.74K | – |
| Q2 FY2023CQ2 2022 | Jul 31, 2022 | -$955.58K | – |
| Q1 FY2023CQ1 2022 | Apr 30, 2022 | -$608.40K | -9435.6% |
| Q4 FY2022CQ4 2021 | Jan 31, 2022 | -$3.70M | – |
| Q1 FY2022CQ1 2021 | Apr 30, 2021 | -$237.80K | – |
| Q4 FY2021CQ4 2020 | Jan 31, 2021 | -$2.11M | – |
| Q3 FY2021CQ3 2020 | Oct 31, 2020 | $6.52K | – |
| Q2 FY2021CQ2 2020 | Jul 31, 2020 | -$207.77K | – |
| Q1 FY2021CQ1 2020 | Apr 30, 2020 | -$129.45K | – |
| Q4 FY2020CQ4 2019 | Jan 31, 2020 | -$598.05K | – |
| Q3 FY2020CQ3 2019 | Oct 31, 2019 | -$312.53K | – |
| Q2 FY2020CQ2 2019 | Jul 31, 2019 | -$431.76K | – |
| Q1 FY2020CQ1 2019 | Apr 30, 2019 | -$554.92K | – |
| Q4 FY2019CQ4 2018 | Jan 31, 2019 | -$538.27K | – |
| Q3 FY2019CQ3 2018 | Oct 31, 2018 | -$429.44K | – |
| Q3 FY2018CQ3 2017 | Oct 31, 2017 | -$45.23K | – |
See a number that looks wrong?